ClinVar Miner

Submissions for variant NM_000404.4(GLB1):c.518T>C (p.Leu173Pro)

dbSNP: rs397515617
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000541694 SCV000629973 pathogenic Mucopolysaccharidosis, MPS-IV-B; GM1 gangliosidosis 2023-05-22 criteria provided, single submitter clinical testing Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GLB1 protein function. ClinVar contains an entry for this variant (Variation ID: 68479). This missense change has been observed in individuals with mucopolysaccharidosis (PMID: 16941474; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 173 of the GLB1 protein (p.Leu173Pro). For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects GLB1 function (PMID: 17664528).
Laboratory of Molecular Genetics MedGen RCV000059352 SCV000105915 not provided GM1 gangliosidosis type 2 no assertion provided not provided

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.